In seven days, Medifactia’s complete system for colonic transit studies makes better health possible for thousands of patients suffering from chronic constipation, chronic diarrhoea and IBS.
Medifactia AB is a privately-held medical device innovator. Headquartered in Stockholm, Sweden, our mission is to improve the diagnostic confidence and clinical outcome for patients suffering from motility disorders. Together with our distributors, we aim to service healthcare practitioners around the world. We service hospital of all sizes, as well as non-hospital market – including physician offices, radiology and surgery centers.
Quality permeates everything we do! For us at Medifactia AB, quality is everything, both in terms of product reliability and delivery dependability. The quality of our medical device Transit-Pellets™ radiopaque markers and our services are a key cause for purchase.